XML 127 R114.htm IDEA: XBRL DOCUMENT v3.22.0.1
Unaudited Quarterly Results - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Quarterly Financial Data [Line Items]                  
Litigation (settlement) provisions $ (5,165) $ 0 $ 0   $ (514) $ (666) $ (5,165) $ (1,180) $ 0
Asset impairment Charges       $ 6,945     0 6,945 0
Unrealized gain loss on investments     $ 10,000       $ 9,707 0 $ 0
Savings in costs as a result of restructuring               70,000  
Favorable Settlement In Respect Of Patent Infringement [Member] | Bruker Corporation And Bruker Daltonic Gmbh [Member]                  
Quarterly Financial Data [Line Items]                  
Litigation settlement amount awarded from the other party   10,000              
Favorable Settlement In Respect Of Patent Infringement [Member] | Bruker Corporation And Bruker Daltonic Gmbh [Member] | Other Nonoperating Income (Expense) [Member]                  
Quarterly Financial Data [Line Items]                  
Litigation (settlement) provisions   $ 10,000              
Medimass [Member]                  
Quarterly Financial Data [Line Items]                  
Impairment of certain intangible assets       10,000       10,000  
Change in Amount of Contingent Consideration, Liability       $ 3,000       $ 3,000